Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Oxygenation in Pediatric OLV
NCT04932746Completed
- Sponsor
- Damascus University
- Start
- Mar 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in esophageal atresia (EA), Hidrocystoma and pleural empyema comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoints: Partial Pressure of Oxygen in Arterial Blood and Intrapulmonary Shunt Fraction. Started Mar 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
esophageal atresia (EA)Hidrocystomapleural empyema
Beyond the preview
Go deeper on NCT04932746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04932746.